In Vivo Assembly of Nanoparticles Achieved through Synergy of Structure-Based Protein Engineering and Synthetic DNA Generates Enhanced Adaptive Immunity.
Nano technology is considered increasingly important for the field of vaccines. Through the nanoparticles multivalent immunogens decor, designed nanovaccines can cause enhanced humoral immunity. However, practical challenges and significant monetary nanovaccines in large scale production has hindered their widespread clinical translation. Human Recombinant Proteins Here, the alternative approach described integrating computational protein modeling and adaptive delivery of synthetic DNA electroporation-mediated, allowing direct in vivo production of nanovaccines. DNA nanoparticle-launched featuring an immunogen shown HIV spontaneously assembled in vivo. DNA-launched nanovaccines induce a strong humoral response than their monomeric counterparts in both rats and guinea pigs, and unique cause CD8 + effector T-cell immunity compared to nanovaccines recombinant proteins. Improvements in vaccine response recapitulation when nanovaccines DNA-launched with alternative scaffolds and...